Trial · NCT03204786
Participant flow30
How many started, completed or left each group, period by period.
1 to 20 of 30
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Treatment Period 1 (4 Weeks) | STARTED | Vasopressin-Vasopressin | 23 | |
| Treatment Period 1 (4 Weeks) | STARTED | Placebo-Vasopressin | 46 | |
| Treatment Period 1 (4 Weeks) | STARTED | Placebo-Placebo | 39 | |
| Treatment Period 1 (4 Weeks) | Received Intervention | Vasopressin-Vasopressin | 23 | |
| Treatment Period 1 (4 Weeks) | Received Intervention | Placebo-Vasopressin | 44 | |
| Treatment Period 1 (4 Weeks) | Received Intervention | Placebo-Placebo | 39 | |
| Treatment Period 1 (4 Weeks) | COMPLETED | Vasopressin-Vasopressin | 22 | |
| Treatment Period 1 (4 Weeks) | COMPLETED | Placebo-Vasopressin | 41 | |
| Treatment Period 1 (4 Weeks) | COMPLETED | Placebo-Placebo | 39 | |
| Treatment Period 1 (4 Weeks) | NOT COMPLETED | Vasopressin-Vasopressin | 1 | |
| Treatment Period 1 (4 Weeks) | NOT COMPLETED | Placebo-Vasopressin | 5 | |
| Treatment Period 1 (4 Weeks) | NOT COMPLETED | Placebo-Placebo | 0 | |
| Treatment Period 2 (4 Weeks) | STARTED | Vasopressin-Vasopressin | 21 | |
| Treatment Period 2 (4 Weeks) | STARTED | Placebo-Vasopressin | 38 | |
| Treatment Period 2 (4 Weeks) | STARTED | Placebo-Placebo | 39 | |
| Treatment Period 2 (4 Weeks) | COMPLETED | Vasopressin-Vasopressin | 19 | |
| Treatment Period 2 (4 Weeks) | COMPLETED | Placebo-Vasopressin | 38 | |
| Treatment Period 2 (4 Weeks) | COMPLETED | Placebo-Placebo | 36 | |
| Treatment Period 2 (4 Weeks) | NOT COMPLETED | Vasopressin-Vasopressin | 2 | |
| Treatment Period 2 (4 Weeks) | NOT COMPLETED | Placebo-Vasopressin | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03204786/flow